282 related articles for article (PubMed ID: 19517460)
1. Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors.
Mao JJ; Stricker C; Bruner D; Xie S; Bowman MA; Farrar JT; Greene BT; DeMichele A
Cancer; 2009 Aug; 115(16):3631-9. PubMed ID: 19517460
[TBL] [Abstract][Full Text] [Related]
2. The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgia.
Kanematsu M; Morimoto M; Honda J; Nagao T; Nakagawa M; Takahashi M; Tangoku A; Sasa M
BMC Cancer; 2011 Oct; 11():436. PubMed ID: 21985669
[TBL] [Abstract][Full Text] [Related]
3. Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort.
Castel LD; Hartmann KE; Mayer IA; Saville BR; Alvarez J; Boomershine CS; Abramson VG; Chakravarthy AB; Friedman DL; Cella DF
Cancer; 2013 Jul; 119(13):2375-82. PubMed ID: 23575918
[TBL] [Abstract][Full Text] [Related]
4. Ageing perceptions and non-adherence to aromatase inhibitors among breast cancer survivors.
Brier MJ; Chambless DL; Chen J; Mao JJ
Eur J Cancer; 2018 Mar; 91():145-152. PubMed ID: 29329697
[TBL] [Abstract][Full Text] [Related]
5. Genomic risk prediction of aromatase inhibitor-related arthralgia in patients with breast cancer using a novel machine-learning algorithm.
Reinbolt RE; Sonis S; Timmers CD; Fernández-Martínez JL; Cernea A; de Andrés-Galiana EJ; Hashemi S; Miller K; Pilarski R; Lustberg MB
Cancer Med; 2018 Jan; 7(1):240-253. PubMed ID: 29168353
[TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors.
Romero SAD; Su HI; Satagopan J; Li QS; Seluzicki CM; Dries A; DeMichele AM; Mao JJ
Breast; 2020 Feb; 49():48-54. PubMed ID: 31678641
[TBL] [Abstract][Full Text] [Related]
7. Aromatase inhibitor-induced arthralgia: a review.
Niravath P
Ann Oncol; 2013 Jun; 24(6):1443-9. PubMed ID: 23471104
[TBL] [Abstract][Full Text] [Related]
8. Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors.
Mao JJ; Su HI; Feng R; Donelson ML; Aplenc R; Rebbeck TR; Stanczyk F; DeMichele A
Breast Cancer Res; 2011 Jan; 13(1):R8. PubMed ID: 21251330
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia.
Niravath P; Hilsenbeck SG; Wang T; Jiralerspong S; Nangia J; Pavlick A; Ademuyiwa F; Frith A; Ma C; Park H; Rigden C; Suresh R; Ellis M; Kent Osborne C; Rimawi MF
Breast Cancer Res Treat; 2019 Sep; 177(2):427-435. PubMed ID: 31218477
[TBL] [Abstract][Full Text] [Related]
10. Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome.
Morales L; Pans S; Verschueren K; Van Calster B; Paridaens R; Westhovens R; Timmerman D; De Smet L; Vergote I; Christiaens MR; Neven P
J Clin Oncol; 2008 Jul; 26(19):3147-52. PubMed ID: 18474874
[TBL] [Abstract][Full Text] [Related]
11. Interventions for the Treatment of Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
Yang GS; Kim HJ; Griffith KA; Zhu S; Dorsey SG; Renn CL
Cancer Nurs; 2017; 40(4):E26-E41. PubMed ID: 27333128
[TBL] [Abstract][Full Text] [Related]
12. [Aromatase inhibitors and arthralgia].
Nagykálnai T; Landherr L; Mészáros E
Magy Onkol; 2011 Mar; 55(1):32-9. PubMed ID: 21617789
[TBL] [Abstract][Full Text] [Related]
13. Aromatase inhibitor-associated arthralgia syndrome.
Burstein HJ
Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
[TBL] [Abstract][Full Text] [Related]
14. Effect of acupuncture on aromatase inhibitor-induced arthralgia in patients with breast cancer: A meta-analysis of randomized controlled trials.
Chen L; Lin CC; Huang TW; Kuan YC; Huang YH; Chen HC; Kao CY; Su CM; Tam KW
Breast; 2017 Jun; 33():132-138. PubMed ID: 28384564
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment?
Moscetti L; Agnese Fabbri M; Sperduti I; Fabrizio N; Frittelli P; Massari A; Pompei L; D'Auria G; Pofi E; Ruggeri EM
Tumori; 2015; 101(5):469-73. PubMed ID: 26108239
[TBL] [Abstract][Full Text] [Related]
16. Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study.
Garcia-Giralt N; Rodríguez-Sanz M; Prieto-Alhambra D; Servitja S; Torres-Del Pliego E; Balcells S; Albanell J; Grinberg D; Diez-Perez A; Tusquets I; Nogués X
Breast Cancer Res Treat; 2013 Jul; 140(2):385-95. PubMed ID: 23868189
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors.
Desai K; Mao JJ; Su I; Demichele A; Li Q; Xie SX; Gehrman PR
Support Care Cancer; 2013 Jan; 21(1):43-51. PubMed ID: 22584732
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of aromatase inhibitor associated arthralgia: known and potential candidate genes and associated biomarkers.
Borrie AE; Kim RB
Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):149-156. PubMed ID: 27635473
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations.
Coleman RE; Bolten WW; Lansdown M; Dale S; Jackisch C; Merkel D; Maass N; Hadji P
Cancer Treat Rev; 2008 May; 34(3):275-82. PubMed ID: 18082328
[TBL] [Abstract][Full Text] [Related]
20. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors.
Irwin ML; Cartmel B; Gross CP; Ercolano E; Li F; Yao X; Fiellin M; Capozza S; Rothbard M; Zhou Y; Harrigan M; Sanft T; Schmitz K; Neogi T; Hershman D; Ligibel J
J Clin Oncol; 2015 Apr; 33(10):1104-11. PubMed ID: 25452437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
